Utilization of Liquid Biopsy in Cancer Diagnosis and Management 2025
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: 31 March 2026 | Viewed by 4764
Special Issue Editor
Interests: gastrointestinal/biliary diseases; metabolic diseases; congenital heart disease; mitochondrial DNA-related cardiomyopathies; carcinogenesis (bone/liver)
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Precision medicine has evolved in the last decade, with ongoing diagnostic and prognostic procedures improvements. Therapeutic protocols have been established, and healthcare institutions and national institutes of health have dramatically changed patient outcomes. The desire to minimize the amount of tissue needed for precision medicine procedures expanded the protocols from peripheral blood for the analysis of cell-free circulating tumor DNA to RNA, circulating tumor cells (CTCs), extracellular vesicles (EVs), and even tumor-educated platelets (TEPs). Next-generation sequencing (NGS) and nanotechnologies are changing our approach to cancer and non-cancerous clinical settings. The College of American Pathologists, of which one of the authors is a house delegate, promotes further the capillarization of liquid biopsy in peripheral rather than central clinical pathology laboratories. We welcome any submissions supporting this technique in the third decade of the 21st century.
Prof. Dr. Consolato M. Sergi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- liquid biopsy
- precision medicine
- cancer diagnostics
- nanotechnologies
- markers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
